Supplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
A variety of dietary interventions has been used in the management of chronic fatigue syndrome (CFS), yet no therapeutic modality has demonstrated conclusive positive results in terms of effectiveness. The main aim of this study was to evaluate the effects of orally administered guanidinoacetic acid (GAA) on multidimensional fatigue inventory (MFI), musculoskeletal soreness, health-related quality of life, exercise performance, screening laboratory studies, and the occurrence of adverse events in women with CFS. Twenty-one women (age 39.3 ± 8.8 years, weight 62.8 ± 8.5 kg, height 169.5 ± 5.8 cm) who fulfilled the 1994 Centers for Disease Control and Prevention criteria for CFS were randomized in a double-blind, cross-over design, from 1 September 2014 through 31 May 2015, to receive either GAA (2.4 grams per day) or placebo (cellulose) by oral administration for three months, with a two-month wash-out period. No effects of intervention were found for the primary efficacy outcome (MFI score for general fatigue), and musculoskeletal pain at rest and during activity. After three months of intervention, participants receiving GAA significantly increased muscular creatine levels compared with the placebo group (36.3% vs. 2.4%; p < 0.01). Furthermore, changes from baseline in muscular strength and aerobic power were significantly greater in the GAA group compared with placebo (p < 0.05). Results from this study indicated that supplemental GAA can positively affect creatine metabolism and work capacity in women with CFS, yet GAA had no effect on main clinical outcomes, such as general fatigue and musculoskeletal soreness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 1×
“Guanidinoacetic acid (GAA) could be of particular interest since it occurs naturally in the human body and acts as an immediate precursor of creatine [12].”
BackgroundCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Craig, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.539 · Cited by 1,062 · cited 1×
“Early clinical studies from the 1950’s revealed favorable effects of GAA (also known as glycocyamine) in patients with chronic illness, including heart disease, arthritis, and depression [14].”
BackgroundPrins, J. B., van der Meer, J. W., & Bleijenberg, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68073-2 · Cited by 974
White, P., Goldsmith, K., Johnson, A., Potts, L., Walwyn, R., DeCesare, J., Baber, H., Burgess, M., Clark, L., Cox, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60096-2 · Cited by 897
Interventions for the Treatment and Management of Chronic Fatigue Syndrome: A Systematic Review
Whiting, P., Bagnall, A.-M., Sowden, A. J., Cornell, J. E., Mulrow, C. D., & Ramírez, G. (2001) · JAMA · doi:10.1001/jama.286.11.1360 · Cited by 509 · cited 1×
“A variety of dietary interventions has been used in the management of CFS, yet no therapeutic modality has demonstrated conclusive positive results in terms of effectiveness [9].”
BackgroundNacul, L. C., Lacerda, E. M., Pheby, D., Campion, P., Molokhia, M., Fayyaz, S., Leite, J. C., Poland, F., Howe, A., & Drachler, M. L. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-91 · Cited by 255 · cited 1×
“Characterized by persistent disabling fatigue that cannot be explained by other conditions, CFS results in a wide range of presenting symptoms such as a substantial reduction in activity level, multi-site muscle and joint pain, or general malaise, with women appearing to be more affected than men [24].”
BackgroundThe prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
Johnston, S., Brenu, Staines, D., & Marshall-Gradisnik (2013) · Clinical Epidemiology · doi:10.2147/clep.s39876 · Cited by 171 · cited 1×
“3% of the general population [5], and it is found to be most prevalent in adults [5–7].”
BackgroundClinical Practice: Chronic fatigue syndrome
Werker, C. L., Nijhof, S. L., & van de Putte, E. M. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2058-8 · Cited by 39 · cited 1×
“CFS occurs with a wide spectrum of signs and symptoms, ranging from fatigue, general muscular pain and weakness through migratory arthralgias, painful axillar or cervical lymphadenopathy, neurocognitive and sleep disorders [4].”
Background
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Kim, D.-Y., Lee, J.-S., & Son, C.-G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113463 · Cited by 24
“Total score (4) [53–56] General fatigue (2) [57,58]”
BackgroundShort‐term GAA loading: Responders versus nonresponders analysis
Ostojic, S. M. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1744 · Cited by 5
Metadata
- Authors
- Ostojic, S., Stojanovic, M., Drid, P., Hoffman, J., Sekulic, D., & Zenic, N.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2016-01-29
- Volume
- 8
- Issue
- 2
- Pages
- 72
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2268499858
- Cited by
- 40
- References
- 9
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.